Conscious sedation with Triazolam in Dentistry
Keywords:
Conscious sedation, Triazolam, DentistryAbstract
Triazolam, when administered orally, possesses a fast initial action, a relatively short action time, few active metabolites, and a high degree of clinical safety. So long as it is used in the appropriate dose, this medication can be considered one of the most suitable agents for conscious sedation in modern dental practices. The objective of this review is to present data related to the parameters of pharmacokinetics, dosage, precautions and contra- indications, as well as the adverse reactions caused by Triazolam, in an attempt to justify its use in dental clinics.
Downloads
References
Andrade ED, Ranali J. Emergências médicas em odontologia. 2ª ed. São Paulo: Artes Médicas, 2004.
Ranali J. Sedação não é anestesia geral, mas permite um trabalho tranquilo e com segurança. In: Anais do 15º Conclave Odontológico Internacional de Campinas. 2003; 104:mar/abr. [acesso em 2004 ago 01]. Disponível em: www. acdc.com.br/anais/joseranali.pdf
Malamed SF. Sedation: a guide to patient management. Florida: Mosby, 1995.
Armonia PL, Tortomano N, Cabral TR, Saraceni- Júnior A. Ansiedade e medo: terapêutica medicamentosa. Rev Odontol Univ Santo Amaro. 2001; 6: 31-4.
Felpel LP. Drogas ansiolíticas e relaxantes musculares de ação central. In: Yagiela JA, Neidle EA, Dowd FJ. Farmacologia e terapêutica para dentistas. 4ªed Rio de Janeiro: Guanabara-Koogan; 2000. p.161-76.
United States of Pharmacopeial Convention. Inc. Drug Information for the Heath Care Professional. 17ª ed. Rockville: USP DI, 1997.
Greenblatt DJ, Harmatz JS, Engelhardt N, Shader RI. Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics: flurazepam, temazepam, and triazolam. Arch Gen Psychiatry. 1989; 46:326- 32.
Kroboth PD, McAuley JW, Kroboth FJ, Bertz RJ, Smith RB. Triazolam pharmacokinetics after intravenous, oral, and sublingual administration. J Clin Psychopharmacol. 1995; 15:259-62.
Greenblatt DJ, Harmatz JS, Shapiro L, Engelhardt N, Gouthro TA, Shader RI. Sensitivity to triazolam in the elderly. N Engl J Med. 1991; 324:1691-8.
Matear DW, Clarke D. Considerations for the use of oral sedation in the institutionalized geriatric patient during dental interventions: a review of the literature. Spec Care Dentist. 1999; 19: 56-63.
Tweedy CM, Milgrom P, Kharasch ED, Kaakko T, Spieker M, Coldwell SE. Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients. J Clin Psychopharmacol. 2001; 21: 268-72.
Karl HW, Milgrom P, Domoto P, et al. Pharmacokinetics of oral triazolam in children. J Clin Psychopharmacol. 1997; 17: 169-72.
Flanagan, D. Oral triazolam sedation in implant dentistry. J Oral Implantol. 2004; 30: 93-7.
Berthold CW, Schneider A, Dionne RA. Using triazolam to reduce dental anxiety. J Am Dent Assoc. 1993; 124: 58-64.
Wynn RL, Bergman AS. Reported adverse effects and drug interactions of triazolam (Halcion). Gen Dent. 2004; 52:378-81.
Penttilä HJ, Nuutinen LS, Kiviluoma KT, Partanen AM. Sublingual triazolam versus peroral diazepam as a premedication for general anaesthesia. Can J Anaesth. 1995; 42:862-8.
Berthold CW, Dionne RA, Corey SE. Comparison of sublingually and orally administered triazolam for premedication before oral surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.1997;84: 119-24.
Coldwell SE, Awamura K, Milgrom P, et al. Side effects of triazolam in children. Pediatr Dent. 1999; 21:18-25.
Pakes GE, Brogden RN, Heel RC, Speight TM, Avery GS. Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs. 1981; 22: 81-110.
Dionne RA, Kaneko Y. Overcoming pain and anxiety in dentistry. In: Dionne R, Phero JC, Becker DE. Management of pain and anxiety in the dental office. Philadelphia: WB Saunders, 2002. p. 134-5.
Ogura C, Nakazawa K, Majima K, et al. Residual effects of hypnotics: triazolam, flurazepam and nitrazepam. Psychopharm. 1980; 68:61-5.
Goodchild JH, Dickinson SC. Anxyiolysis in dental practice: a report of three cases. Gen Dent. 2004; 52: 264-8.
Quarnstrom FW, Donaldson M. Triazolam use in the dental setting: a report of 270 uses over 15 years. Gen Dent. 2004; 52:496-501.
Kaufman E, Hargreaves KM, Dionne RA. Comparison of oral triazolam and nitrous oxide with placebo and intravenous diazepam for outpatient premedication. Oral Surg Oral Med Oral Pathol. 1993; 75:156-64.
Feck AS, Goodchild JH. Reabilitation of a fearful dental patient with oral sedation: Utilizing the incremental oral administration technique. Gen Dent. 2005; 53:22-6.
